Vulvar Lichen Sclerosus

Approved for this indication (1)

• dienestrol

Phase 4 trials (1)

• clobetasol

Phase 3 trials (1)

• plasma rich in growth factors

Phase 2 trials (4)

• progesterone
• tacrolimus
• platelet-rich plasma
• mc2-25

Other trials (4)

• aminolevulinic acid
• mometasone
• methylene blue
• sodium chloride

Organization Involved with Phase 3 Indications (1)

• Georgetown University

Organization Involved with Phase 2 Indications (7)

• Astellas
• Novartis
• Center for Vulvovaginal Disorders
• University of Bern
• University of Valencia
• University of Montreal
• St. Justine's Hospital

Organization Involved with Other Experimental Indications (4)

• Cantonal Hospital, Frauenfeld
• RWTH Aachen University
• University of Nove de Julho
• Hospital Perola Byington